EU’s New Health Threats Body Could Speed Arrival Of New Antibiotics
‘Pull’ Incentives Will Be Vital In Spurring Drug Development
Europe is preparing a “preparatory action” to review existing measures for tackling antimicrobial resistance, identify the gaps, and to determine what products will be needed in future.
You may also be interested in...
With proposals for an overhaul of the EU medicines legislation due at the end of this year, EFPIA has published its formal response to the European Commission’s consultation with suggestions for facilitating new antibiotic development, testing new regulatory approaches to novel medicines, and tackling medicine shortages.
The European Commission has dismissed concerns about the operation of its new emergency response body, saying it will ensure the EU is well prepared for tackling future pandemics and other threats. HERA will complement, not duplicate, work conducted by existing agencies such as the European Medicines Agency, delegates heard at this week’s European Health Forum Gastein virtual conference.
The European Commission wants to learn from mistakes made in the COVID-19 crisis and to create an end-to-end system to co-ordinate funding, clinical research and manufacturing of vaccines.